Application 207146
- Type
- ANDA
- Sponsor
- WOCKHARDT BIO AG
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | INJECTABLE;INJECTION | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | No | No |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A207146-001 | PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM; TAZOBACTAM SODIUM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A207146-001 | AP |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | 8869cabd3fbd… | |
| 2020-11-12 02:37 UTC | 2020-11 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | c0c555d07b60… | |
| 2019-12-14 00:12 UTC | 2019-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | 3f01610625f2… | |
| 2019-09-15 20:21 UTC | 2019-09 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | b00525d2431f… | |
| 2019-07-19 19:46 UTC | 2019-07 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | 2017-03-17 | ea99ee380514… | |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A207146-001 | PIPERACILLIN AND TAZOBACTAM | EQ 36GM BASE/VIAL;EQ 4.5GM BASE/VIAL | INJECTABLE / INJECTION | AP | RS | 2017-03-17 | e64feba35796… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-18 06:07:40 | 2026-07 | A207146-001 | AP | 1 | caaa826d4ba7… |
| 2026-02-19 14:30 UTC | 2026-02 | A207146-001 | AP | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A207146-001 | AP | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A207146-001 | AP | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A207146-001 | AP | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A207146-001 | AP | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A207146-001 | AP | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A207146-001 | AP | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A207146-001 | AP | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A207146-001 | AP | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A207146-001 | AP | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A207146-001 | AP | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A207146-001 | AP | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A207146-001 | AP | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A207146-001 | AP | 1 | 8072bd15b7f6… |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A207146-001 | AP | 1 | 5c6f7cd8ea54… |
| 2022-04-08 23:34 UTC | 2022-04 | A207146-001 | AP | 1 | 5d02ea3f76ae… |
| 2022-04-04 05:41 UTC | 2022-04 | A207146-001 | AP | 1 | 4b0b4de00fa7… |
| 2019-12-13 00:20 UTC | 2019-12 | A207146-001 | AP | 1 | 74a2ff9319b5… |
| 2022-03-09 01:35 UTC | 2022-03 | A207146-001 | AP | 1 | bb7c543d1eb4… |
| 2021-12-28 21:50 UTC | 2021-12 | A207146-001 | AP | 1 | 782e0a99824c… |
| 2021-05-05 16:15 UTC · 3 captures of this ZIP | 2021-05 | A207146-001 | AP | 1 | 87673890dc5c… |
| 2021-03-12 10:30 UTC | 2021-03 | A207146-001 | AP | 1 | 5aa47cf7b7d7… |
| 2020-12-22 03:56 UTC | 2020-12 | A207146-001 | AP | 1 | 8869cabd3fbd… |
| 2020-11-12 02:37 UTC | 2020-11 | A207146-001 | AP | 1 | c0c555d07b60… |
| 2019-12-14 00:12 UTC | 2019-12 | A207146-001 | AP | 1 | 3f01610625f2… |
| 2019-09-15 20:21 UTC | 2019-09 | A207146-001 | AP | 1 | b00525d2431f… |
| 2019-07-19 19:46 UTC | 2019-07 | A207146-001 | AP | 1 | ea99ee380514… |
| 2024-03-16 18:09 UTC · 4 captures of this ZIP | 2024-03 | A207146-001 | AP | 1 | 6a51e52b5d6a… |
| 2024-02-18 07:12 UTC | 2024-02 | A207146-001 | AP | 1 | 1c564ffb4f44… |
| 2023-12-20 04:57 UTC | 2023-12 | A207146-001 | AP | 1 | ea1830bbd6c7… |
| 2023-11-28 05:40 UTC · 2 captures of this ZIP | 2023-11 | A207146-001 | AP | 1 | a72a2bbeb626… |
| 2023-10-25 00:34 UTC · 2 captures of this ZIP | 2023-10 | A207146-001 | AP | 1 | 9b2671bbb829… |
| 2023-07-15 15:27 UTC · 2 captures of this ZIP | 2023-07 | A207146-001 | AP | 1 | a67488948f0b… |
| 2023-06-13 01:57 UTC · 3 captures of this ZIP | 2023-06 | A207146-001 | AP | 1 | 3f0d92c62455… |
| 2023-05-13 08:27 UTC | 2023-05 | A207146-001 | AP | 1 | 053a50430f4f… |
| 2023-01-26 05:58 UTC | 2023-01 | A207146-001 | AP | 1 | 3bdfa0b2c4d7… |
| 2022-11-12 20:34 UTC · 5 captures of this ZIP | 2022-11 | A207146-001 | AP | 1 | 3a93d1ddd44b… |
| 2022-10-28 04:53 UTC | 2022-10 | A207146-001 | AP | 1 | f41ea6bd6efb… |
| 2022-09-29 23:25 UTC | 2022-09 | A207146-001 | AP | 1 | e64feba35796… |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | WG Critical Care, LLC | 17a400ae-cbaa-4d07-95f4-c6917dfc0585 | 2026-06-24 | Boxed warning, Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Civica, Inc. | 19e89f8b-316b-4dd2-9724-bfe0faeba408 | 2025-12-12 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | Civica, Inc. | 7aebc0e6-89db-4ef0-b5ab-d6b3199bcfc4 | 2025-09-08 | Warnings, Adverse reactions | piperacillin and tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Avenacy, LLC | 668a2730-e95a-4639-a506-ae95a6502ca1 | 2025-09-01 | Boxed warning, Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Eugia US LLC | 39e19789-de4b-4fd1-ab1c-92f59496f496 | 2025-08-19 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Eugia US LLC | a5d8625e-e630-4076-bc55-46ebe861c6a5 | 2025-08-08 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| piperacillin and tazobactam | PIPERACILLIN AND TAZOBACTAM | ONESOURCE SPECIALTY PHARMA LIMITED | 28258745-12e4-4f0f-b318-4a1a1bebc928 | 2025-07-21 | Warnings, Adverse reactions | piperacillin and tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Avenacy, LLC | 9114cea1-3338-487e-87fa-cc3a409d501a | 2025-07-07 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | BluePoint Laboratories | 1aba753c-d0c2-4b35-917a-9143dd4be468 | 2025-06-20 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Apotex Corp. | 2c8f06a2-49b2-4169-94ef-182d13d248bf | 2025-05-21 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | c5cddf50-e486-4ffb-9bc6-ed67ad6bc154 | 2025-04-14 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | a798faf5-cd97-4e35-a700-94c372978c46 | 2025-04-14 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | 6a894b94-171f-4217-81a2-0e84796b0b41 | 2025-04-11 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Fresenius Kabi USA, LLC | c8e3cc43-238d-4a23-95dc-157c85f83184 | 2025-04-10 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Provepharm Inc. | 68d5384d-1691-4afc-8a1a-488f8e2ef2c5 | 2025-02-26 | Boxed warning, Warnings, Adverse reactions | Piperacillin and Tazobactam |
| PIPERACILLIN AND TAZOBACTAM | PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM | Provepharm Inc. | bc26ffd8-1a6e-4e16-91c1-ec67c928b3bf | 2025-02-26 | Warnings, Adverse reactions | PIPERACILLIN AND TAZOBACTAM |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Sandoz Inc | 9b682c66-61c6-4ade-baf4-9d68911a16b8 | 2024-10-30 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Hospira, Inc | 4d3f4b69-b0b9-494f-9cda-4537fa420d47 | 2024-10-25 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN AND TAZOBACTAM | Shandong Anxin Pharmaceutical Co., Ltd. | 420196a5-f62d-473f-84d8-d7fc3f31c3d3 | 2024-10-17 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
| Piperacillin and Tazobactam | PIPERACILLIN SODIUM,TAZOBACTAM SODIUM | Fresenius Kabi USA, LLC | fc4d1e35-23eb-4654-8691-ae5bfd50a48a | 2024-10-16 | Warnings, Adverse reactions | Piperacillin and Tazobactam |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 22607-679 | Piperacillin and Tazobactam | piperacillin sodium and tazobactam sodium | Mitim S.r.l. | ANDA | Current |
| 64679-679 | Piperacillin and Tazobactam | piperacillin sodium and tazobactam sodium | Wockhardt USA LLC. | ANDA | Current |
| 64679-679 | Piperacillin and Tazobactam | piperacillin sodium and tazobactam sodium | Wockhardt USA LLC. | ANDA | Current |
| 64679-679 | Piperacillin and Tazobactam | piperacillin sodium and tazobactam sodium | Wockhardt USA LLC. | ANDA | Current |
| 64679-679 | Piperacillin and Tazobactam | piperacillin sodium and tazobactam sodium | Wockhardt USA LLC. | ANDA | Current |